IP Library Granted Patent US 12,674,011
Granted Patent B2
US 12,674,011 · App. 18/254,334 · Granted Jul 7, 2026

Modified polyethylene resins and process for making the same

Inventors: Alexander Williamson (Rosharon, TX); Rahul Sharma (Pearland, TX)
Assignee: Dow Global Technologies LLC
C08F210/16B29C48/022C08F4/6421C08F4/6545C08F4/65916C08J3/12C08K5/1345C08K5/14C08K5/524C08L23/26C08F2810/10C08J2323/08C08L2023/44C08L2207/068
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,674,011
App. No.
18/254,334
Filed
May 24, 2023
Granted
Jul 7, 2026
Kind
B2
Art Unit
1764
USPC
525/240
Abstract

The present invention is a process to modify a starting polyethylene resin composition. In the process, a starting polyethylene resin composition is extruded with at least one primary antioxidant and a free-radical generator to make a modified polyethylene resin composition.

Claims (32)

1 . A process to make a modified polyethylene formulation, which process comprises the steps of:

a) providing a starting polyethylene resin composition (SPEC) containing one or more polyethylene (co) polymer(s), wherein the SPEC has a melt index (12) of from 0.5 dg/min to 5 dg/min and contains

i) from 0 to no more than 1.5 weight percent (based on the total weight of SPEC) of a high molecular weight Cumulative Detector Fraction-Light Scattering (CDF LS ) fraction with a molecular weight (MW) of greater than 5,000,000 grams per mole (g/mol) and

ii) from 0 to no more than 0.3 weight percent (based on the total weight of SPEC) of an ultra-high molecular weight CDF LS fraction with a molecular weight (MW) of greater than 10,000,000 g/mol;

b) extruding and mixing together in a melt

i) the SPEC,

ii) a total quantity of one or more primary antioxidants that is effective to provide a concentration of least 2001 parts of the one or more primary antioxidants per 1 million parts by weight of the modified polyethylene formulation (“ppmw”), and

iii) from 11 to 250 parts of free-radical generator per 1 million parts of the SPEC, by weight (“ppmw”), and

iv) optionally, a total quantity of one or more secondary antioxidants that is effective to provide a concentration of at least 395 ppmw of the one or more secondary antioxidants in the modified polyolefin formulation,

wherein the one or more primary antioxidants and the optional one or more secondary antioxidants are collectively referred to as the “primary and any secondary antioxidant(s)”;

wherein the melt is maintained at a temperature and for a time sufficient to substantially decompose the free-radical generator without substantially degrading the polyethylene resin or the one or more primary antioxidants, such that a modified polyethylene formulation is produced which has:

(i) a modified polyethylene resin component (MPEC) having

1. At least 2 weight percent (based on the total weight of MPEC) of a high molecular weight CDF LS fraction with a molecular weight (MW) of greater than 5,000,000 g/mol and

2. At least 0.3 weight percent (based on the total weight of MPEC) of an ultra-high molecular weight CDF LS fraction with a molecular weight (MW) of greater than 10,000,000 g/mol; and

(ii) a total of at least 2,001 parts of the one or more primary antioxidant per 1 million parts of the MPEC by weight (ppmw); and

(iii) less than 10 weight percent of polyethylene gels (based on the total weight of MPEC), and

(iv) optionally, a total of at least 395 ppmw of the one or more secondary antioxidants.

2 . The process of claim 1 characterized by any one of limitations (i) to (vii): (i) wherein at least some of the from 11 to 250 ppmw of the free-radical generator is added before the adding of the primary and any secondary antioxidant(s); (ii) wherein at least some of the from 11 to 250 ppmw of the free-radical generator is added simultaneously with the adding of the primary and any secondary antioxidant(s); (iii) wherein at least some of the from 11 to 250 ppmw of the free-radical generator is added after the adding of the primary and any secondary antioxidant(s); (iv) a combination of (i) and (ii) but not (iii); (v) a combination of (i) and (iii) but not (ii); (vi) a combination of (ii) and (iii), but not (i); and (vii) a combination of each of (i), (ii), and (iii).

3 . The process of claim 1 wherein all of the from 11 to 250 ppmw of the free-radical generator is added after or simultaneously with the adding of the primary and any secondary antioxidant(s).

4 . The process of claim 1 wherein all of the from 11 to 250 ppmw of the free-radical generator is added simultaneously with the adding of the primary and any secondary antioxidant(s).

5 . The process of claim 1 wherein the free-radical generator is an organic peroxide having a molecular weight of 200 to 1000 g/mol and the free-radical generator is added in a quantity of 20 to 250 parts free radical generator per one million parts of SPEC, by weight.

6 . The process in claim 1 characterized by any one of limitations (i) to (iii): (i) wherein and the one or more secondary antioxidants is/are used and the total quantity of the one or more secondary antioxidants that is added is effective to provide from 400 to 2000 ppmw of the one or more secondary antioxidants in the modified polyethylene formulation (based on the weight of MPEC); (ii) wherein the MPEC has a total of from 2001 to 4500 ppmw of the one or more primary antioxidants (based on the weight of MPEC); and (iii) both (i) and (ii).

7 . The process in claim 1 wherein melt strength of the modified polyethylene formulation is at least 2 cN higher than the melt strength of the starting polyethylene resin component.

8 . The process in claim 1 wherein melt-index (I 2 ) of the modified polyethylene formulation is from 0.05 dg/min to 2.0 dg/min.

9 . The process of claim 1 wherein the content of the high molecular weight CDF LS fraction with a molecular weight (MW) of greater than 5,000,000 g/mol in the modified polyethylene formulation is between 2.4 weight percent and 30 weight percent, based on the total weight of MPEC.

10 . The process of claim 1 wherein the content of the ultra-high molecular weight CDF LS fraction with a molecular weight (MW) of greater than 10,000,000 g/mol in the modified polyethylene formulation is between 0.4 weight percent and 15 weight percent, based on the total weight of MPEC.

11 . The process of claim 1 wherein the modified polyethylene formulation contains less than 3 weight percent gels based on the weight of MPEC.

12 . The process of claim 1 wherein the starting polyethylene resin component contains less than 0.20 vinyl groups per 1000 carbon atoms.

13 . The process of claim 1 wherein the process is carried out in an extruder-pelletizer.

14 . The process of claim 1 wherein the process is carried out in multiple extruders, by extruding the starting polyethylene resin component on a first extruder with part of the free-radical generator and/or the primary and any secondary antioxidant(s) and then extruding the resulting composition again on a second extruder with the remaining free-radical generator and/or the primary and any secondary antioxidant(s); wherein

either: (a) the first and second extruders are in communication with a conveying operation all located in a same manufacturing plant and the composition resulting from the first extruder is fed to the second extruder via the conveying operation; or (b) the first and second extruders are located in different manufacturing plants and the composition resulting from the first extruder is transported by vehicle therebetween.

15 . A modified polyethylene formulation made by the process of claim 1 .

Continuity (2)
Provisional Application 63128929 · Dec 22, 2020
Related Publication 20240010772A1 · Jan 11, 2024
References Cited (49)
US 3003000A · Milas · 1961 [cited by applicant]
US 4352915A · Mashita et al. · 1982 [cited by applicant]
US 5627242A · Jacobsen et al. · 1997 [cited by applicant]
US 5882750A · Mink et al. · 1999 [cited by applicant]
US 5925448A · Moy et al. · 1999 [cited by applicant]
US 6417289B1 · Shirodkar et al. · 2002 [cited by applicant]
US 6445642B2 · Murakami · 2002 [cited by applicant]
US 7498282B2 · Patel et al. · 2009 [cited by applicant]
US 7847029B2 · Butler et al. · 2010 [cited by applicant]
US 8968851B2 · Walter et al. · 2015 [cited by applicant]
US 8987382B2 · Demirors et al. · 2015 [cited by applicant]
US 10759927B1 · Karjala et al. · 2020 [cited by applicant]
US 10759928B2 · Brown et al. · 2020 [cited by applicant]
US 11046841B2 · Lin et al. · 2021 [cited by applicant]
US 11492467B2 · Lin et al. · 2022 [cited by applicant]
US 20050090464A1 · Visser et al. · 2005 [cited by applicant]
US 20110171407A1 · Mazzola et al. · 2011 [cited by applicant]
US 20140342141A1 · Cui et al. · 2014 [cited by applicant]
US 20170020936A1 · Versalovic et al. · 2017 [cited by applicant]
US 20190100644A1 · Williamson et al. · 2019 [cited by applicant]
WO 2005023912 · 2005 [cited by applicant]
WO 2006045501 · 2006 [cited by applicant]
WO 2008104371 · 2008 [cited by applicant]
WO 201185377 · 2011 [cited by applicant]
WO 201185379 · 2011 [cited by applicant]
WO 2011085371 · 2011 [cited by applicant]
WO 2011085375 · 2011 [cited by applicant]
WO 2012134700 · 2012 [cited by applicant]
WO 2013006409 · 2013 [cited by applicant]
WO 2013101930 · 2013 [cited by applicant]
WO 2015047841 · 2015 [cited by applicant]
WO 2016204951 · 2016 [cited by applicant]
WO 2017112503 · 2017 [cited by applicant]
WO 2017112510 · 2017 [cited by applicant]
WO 2017146981 · 2017 [cited by applicant]
WO 2017172273 · 2017 [cited by applicant]
WO 2017201110 · 2017 [cited by applicant]
WO 2018039968 · 2018 [cited by applicant]
WO 2018160558 · 2018 [cited by applicant]
WO 2018175277 · 2018 [cited by applicant]
WO 2019067239 · 2019 [cited by applicant]
WO 2019105851 · 2019 [cited by applicant]
Bionov, “All Antioxidants are not Equivalent, The Most Effective Antioxidants are Produced Endogenously” 2016. [cited by applicant]
Busico, “H NMR Analysis of Chain Unsaturations in Ethene/1-Octene Copolymers Prepared with Metallocene Catalyss at High Temperature”, Macromolecules, 2005, vol. 38, p. 6988. [cited by applicant]
Jung, “Analysis of Chain Branch of Polyolefins by a New Proton NMR Approach”, Anal. Chem., 2016, vol. 88, pp. 1516-1520. [cited by applicant]
Milas, “Studies in Organic Peroxides. XXV. Preparation, Separation and Identification of Peroxides Derived from Methyl Ethyl Ketone and Hydrogen Peroxide”, J. Am. Chem. Soc, 1959, vol. 81, pp. 5824-5826. [cited by applicant]
Williams, “The Construction of a Polyethylene Calibration Curve for Gel Permeation Chromatography using Polystyrene Fractions,” 1968, vol. 6, p. 621-624. [cited by applicant]
Zhou, “Analyses of Short Chain Branches in Polyolefins with Improved 1H NMR Spectroscopy”, Anal. Chem., 2020, vol. 92, pp. 8350-8355. [cited by applicant]
PCT/US2021/046407, International Search Report and Written Opinion with a mailing date of Nov. 16, 2021. [cited by applicant]